Recent advancements in high-level synthesis of the promising clinical drug, prodigiosin

Published: 12/01/2019
Recent advancements in high-level synthesis of the promising clinical drug, prodigiosin
Source: LINK.SPRINGER.COM

Abstract Prodigiosin, a red linear tripyrrole pigment and a member of the prodiginine family, is normally secreted by the human pathogen Serratia marcescens as a secondary metabolite. Studies on prodigiosin have received renewed attention as a result of reported immunosuppressive, antimicrobial and anticancer properties. High-level synthesis of prodigiosin and the bioengineering of strains to synt

Read more
Related news
Comment
FACEBOOK